Failure To Cure Pleading Deficiencies Dooms Investor Suit Against Tech Company

Mealey's (November 14, 2022, 2:22 PM EST) -- SAN FRANCISCO — Shareholders in a securities class action have failed to cure the pleading deficiencies that led to a prior dismissal of their federal securities law claims brought against a technology company and several of its current and former officers and directors regarding statements the defendants made about the company’s technological capabilities and product offerings, a federal judge in California ruled in dismissing the claims without leave to amend....